Barriers to fertility preservation among cancer patients in the Middle East and North Africa (MENA) region: a scoping review Authors: Gerald Amandu Matua, Eilean Rathinasamy Lazarus, Joshua Kanaabi Muliira, Asma Al Yahyaei, Sulaiman Al Sabei, Prossy Nandawula Published: 2026 ABSTRACT IntroductionAdvances in cancer care have increased survival and demand for quality cancer survivorship care. Among survivors of reproductive age, the sequelae of gonadotoxic cancer treatments such as infertility presents a key survivorship and quality-of-life concern. In the Middle East and North Africa (MENA) access to fertility preservation (FP) services is inadequate, limiting future fertility and dreams of childbirth.PurposeTo synthesize scientific literature to identify the barriers to FP among cancer patients in the MENA region.MethodsDatabase searches (PubMed, Scopus, Web of Science, Google Scholar, CINAHL, and ProQuest) of articles about FP/oncofertility barriers (January 2015 and June 2025) yielded 243 articles. Articles were included only if they focused on cancer patients or addressed parents and healthcare providers of patients with cancer eligible for FP (n = 22).ResultsContent analysis led to four themes of patient, provider, healthcare system, and socio-cultural related barriers. The key patient-related barriers were lack of knowledge about FP and fear of delaying cancer treatment. The common provider-related barriers were inadequate knowledge and confidence about FP, poor patient teaching, and biases. The main healthcare system barriers were cost and lack of access to FP services. The key social-cultural barriers were the hindrances arising from social norms, cultural values, and religious beliefs about FP.ConclusionCancer patients in the MENA region face complex intersecting barriers to FP. These challenges may differ from one country to another, but require multidisciplinary culturally informed approaches that integrate education, policy reforms, and religious engagement. We highlight future directions to aid equitable access to FP for cancer survivors.Implications for practiceImproving access to FP for cancer patients and survivors in the MENA region requires culturally sensitive, multidisciplinary interventions. Entrenched systems to ensure early FP counseling, provider education and training, and patient education about FP are a reasonable starting point. Introduction The global rise in cancer diagnoses among adolescents and young adults has heightened the risk of infertility due to gonadotoxic treatments such as chemotherapy, radiation therapy, and surgical interventions [1, 2]. As a result, individuals of reproductive age with cancer depend on fertility preservation (FP) methods such as cryopreservation of sperms, oocytes (eggs), embryos, and ovarian or testicular tissue, ovarian transposition, and conservative gynecologic surgery to maintain plans of childbirth and safeguard future fertility [3–5]. Indeed, many patients with cancer are now able to have children using FP and associated reproductive technologies [6]. Fertility preservation (FP) refers to methods for saving or protecting eggs, sperms, oocytes, embryos, or other reproductive tissues for potential future use in having biological children [3]. FP is emerging as a critical component of cancer care due to advances in early detection and treatments that have improved survival rates among cancer patients of reproductive age [3, 7]. Each year, many females and males of childbearing potential are diagnosed with cancer globally and face the risk of temporary or permanent infertility due to adverse effects of cancer therapies [8]. Consequently, FP has become a central pillar of survivorship care, prompting calls from the International Federation of Gynecologists and Obstetrics (FIGO) to ensure integration of this care into oncology services [9, 10]. Moreover, the lack of access to FP has profound clinical and psychosocial consequences, because when patients cannot access FP, they face the risk of permanent loss of biological parenthood, which is increasingly recognized as a major determinant of long-term quality of life. Eligible patients without access to FP can suffer mental health disorders such as anxiety and depression; they could live lives full of chronic post-treatment regret and distress due to not receiving adequate counseling or access to FP; may experience social challenges associated with involuntary childlessness such as a sense of lost identity, social death, and stigma due to childlessness [9, 10]. In some cases, patients may choose to delay or refuse cancer treatment due to concerns about infertility [9, 10]. All these social and clinical challenges have implications for the cancer care system and require focused attention and studies to address issues related to FP and oncofertility in general. The field of oncofertility is experiencing increased attention and rapid technological advancements in FP and services for both men and women, including sperm banking, oocyte, or embryo cryopreservation, and ovarian or testicular tissue preservation. These technologies and treatment options present patients with cancer and later cancer survivors with a real possibility of preserving their biological ability to become parents after cancer treatment [3, 4]. In support of this trend, international guidelines by FIGO and the American Society of Clinical Oncologists recommend prompt fertility counseling and referral to fertility specialists for eligible patients before initiation of cancer treatment [5, 7]. Despite these global advancements, the uptake of FP in the MENA region lags significantly, and it is potentially constrained by a constellation of barriers [11, 12]. For instance, research from MENA countries indicates that patients of reproductive age often lack adequate information, counseling, and access to family planning services before cancer treatment, despite their future interest in having children [12]. For younger patients who are diagnosed with cancer before finishing their reproductive plans, this situation can be troubling and emotionally challenging. Moreover, infertility as a medical complication often leads to psychological distress, emotional challenges, and reduced quality of life [13]. In societies where having children is viewed as an important aspect of both being a woman and a man, social norms about fertility, marriage, and family responsibilities can place additional pressures on cancer survivors [13]. These factors can contribute to challenges such as loss of hope, low quality of life, grief, and social stigma among cancer survivors. Thus, in oncology and cancer care in general, there is a need to prioritize both cancer survival and comprehensive survivorship care, with FP as a central pillar of the care needed by cancer patients of reproductive age. Unfortunately, the literature on oncofertility and FP in the MENA region remains sparse, fragmented, and lacks a systematic synthesis of the barriers to FP. Identifying and understanding the barriers to FP in the MENA region is essential, as factors like religion, culture, and gender beliefs shape social life and may necessitate tailored interventions for patients at risk of cancer therapy-induced infertility. Aim The review aimed to identify the common barriers to FP faced by patients with cancer and cancer survivors in the Middle East and North African (MENA) region. The MENA region includes countries such as Algeria, Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Palestinian Territory, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emirates, and Yemen. The review considered one research question (What are the barriers to fertility preservation faced by cancer patients in the MENA region?) and provides recommendations about potential appropriate interventions to help overcome the barriers and enhance access and uptake of FP by cancer patients and survivors. Methods This scoping review systematically mapped studies published in English in peer-reviewed scientific journals from the period of January 2015 to June 2025 to synthesize and identify barriers to FP among cancer patients in the MENA region. The review focused on cancer patients of reproductive age in MENA countries (Population), explored barriers to fertility preservation (Concept), and included studies conducted in any healthcare or community setting within this region (Context). After identifying the research team with the necessary experience, the six steps for conducting a scoping review were followed and these include: (1) Identifying the research question, (2) Identifying the relevant studies, (3) Selecting the studies to be included, (4) Charting the data, (5) Collating, summarizing, and reporting results, and (6) Consulting stakeholders [14]. The review was further guided by the PRISMA extension for scoping reviews (PRISMA-ScR) guidelines [15], to help ensure methodological rigor and transparency. The synthesized evidence was used to develop evidence-based recommendations regarding approaches to reduce barriers or enhance access to FP and oncofertility services in the MENA region, where culture and religion play a key role in social life. To maintain consistency during appraisal and interpretation and due to the limited reliable resources for translation of articles written in other languages, only articles published in English were included. The review team consisted of researchers with expertise in oncology nursing, reproductive health, healthcare systems, health services, management, and healthcare in the MENA region. Their combined clinical and research backgrounds and expertise ensured a multifaceted analysis and interpretation of barriers, while paying attention to the culture, religion, and policy-level challenges specific to the region. Search strategy The present review systematically retrieved studies published in the period of January 2015 to June 2025 that were exploring aspects related to FP and barriers to FP following the diagnosis of cancer in the MENA region. The search was conducted systematically in databases including PubMed, Scopus, Web of Science, Google Scholar, CINAHL, and ProQuest. The search descriptors were grouped and utilized for searching in combination: 1-“cancer patients” or “oncology patients” * AND “Middle EAST” with names of countries, 2-FP intervention (the search on fertility preservation or oncofertility generated the same citation), and 3-Barrier term: “Access barriers” (or “cultural/religious challenges” and “financial constraints”). The reference lists of eligible articles were also hand-searched to bridge database deficiencies. The period from the year 2015 to 2025 was selected since this is when the international FP guidelines were first published and utilized in the Middle East region. Study selection and screening Searches of databases resulted in 243 citations (see Fig. 1), and these were managed in EndNote to remove duplicates (n = 23). The second step of screening involved two phases: (1) the review of titles/abstracts based on the inclusion criteria i.e., a study based on a sample from the MENA region and reporting about primary data about barriers to FP, and (2) full text of the article available for review. Three authors independently screened each article, and disagreements (n = 7) were resolved by the fourth reviewer through consensus discussions. Disputed articles needed unanimous votes to be included/excluded following structured discussions based on predefined criteria (e.g., relevance to barriers and sample from the MENA region). Such methods protected against bias and ensured that only studies on FP barriers from the MENA region were reviewed. Fig. 1Flow chart of study selection according to Prisma guidelines [15] Flow chart of study selection according to Prisma guidelines [15] Inclusion and exclusion criteria Articles were included if they were: focusing on FP or oncofertility in a sample of cancer patients (adults/adolescents), parents of adolescents with cancer, and/or healthcare professionals in the MENA region; about barriers to FP such as knowledge gaps, cost, cultural/religious beliefs, legal restrictions, access issues, provider attitudes, or systemic challenges; primary studies using qualitative, quantitative, or mixed-methods designs; and published between 2015 and 2025 in English. The review excluded reviews, editorials, protocols, and opinion pieces. The lack of funding and reliable platforms to translate in all languages used in the MENA region limited our ability to translate non-English articles. Due to the limited number of studies on FP, both qualitative and quantitative primary studies were included to provide a more comprehensive overview map of the barriers to FP. The use of studies of diverse designs, and that used various outcome measures also prevented the use of a metanalysis approach. Data extraction Data extraction was performed using established standards of tables and protocol to ensure the rigor of the methodology. The following information was systematically extracted from each study: (1) bibliographic details (author, year, country), (2) study details (design, setting, sample size), (3) type of participant, and (4) the reported barriers. The data were summarized as presented in Table 1. The extracted data was confirmed by double verification, with inconsistencies reconciled during consensus meetings. This procedure guaranteed that FP-related issues in the MENA region are well-documented with limited extraction bias. Quality appraisal The methodological quality of the twenty-two included studies was assessed by at least two reviewers using Joanna Briggs Institute (JBI) checklists with design-specific thresholds [16]. For instance, the cross-sectional studies are rated on eight (8) criteria as Excellent (87–100%), Good (75%), or Needs Improvement (≤ 63%). The quasi-experimental designs (9 criteria) are categorized as High Quality (89–100%), Moderate (67–78%), and Low (≤ 56%). The prospective cohort III studies (11 criteria) are categorized as Strong (82–100%), Moderate (55–73%), or Weak (≤ 45%). The qualitative studies are rated on 10 items, and the final score is categorized as Rigorous (90–100%), Adequate (70–80%), or Deficient (≤ 60%). The results of the quality appraisals of all the cross-sectional, quasi-experimental, retrospective, and qualitative studies included in the review are presented in Fig. 2; Tables 2, 3 and 4, respectively. Fig. 2Quality appraisal of quantitative studies using the JBI critical appraisal checklist for analytical cross-sectional studies Quality appraisal of quantitative studies using the JBI critical appraisal checklist for analytical cross-sectional studies Table 1Summary of the studies included in the reviewAuthorCountryParticipantsStudy designStudy outcomes or measuresMain findingsIdentified barriersRashed et al., 2018 [17]EgyptSingle females (20 to 25 years of age) diagnosed with cancer and going to receive cancer treatment.(N = 100)Quasi-experimental (pre-post evaluation after cryopreservation counseling)• Knowledge and attitude toward cryopreservation• Knowledge about cryopreservation was poor (73%) and improved to good (78%) after counseling.• Attitudes of the patients were negative (63%) and improved to positive (82%) after the counseling.• Poor knowledge and negative attitudes of patients about cryopreservationRashidi et al., 2018 [18]IranFemale cancer patients are referred to the infertility center.(N = 77)Retrospective study• Desire FP• The cause of refusing FP• Thirty-eight people were recruited for FP.• Of the thirty-eight patients recruited for FP, four had received chemotherapy before referring.• One patient had radiotherapy before the referral.• Other reasons for not getting FP: cost, fear of delaying cancer treatment, fear of ovarian stimulation complications.• Inconsistent counseling and patient education about fertility before starting cancer treatment.• Cost of onco-fertility care• Patients lack knowledge.• Patient’s fear of complications related to fertility treatment.• Patient’s fear of delaying cancer treatmentKhalife et al., 2019 [19]LebanonParents of Female patients (ages 11–20 years) receiving cancer treatment(N = 70)Survey• Knowledge of the effect of cancer treatment on fertility, FP options, and readiness for FP.•• Only 44.3% were aware of the adverse effects of cancer treatment on fertility before initiation of treatment.• Only 28.6% were concerned about the effect of treatment on their daughter’s fertility.• Patients with higher levels of education were concerned about fertility-related issues.• 85.6% were not offered the option of FP.• Reason for not discussing FP: difficulty finding proper facilities (22.8%), fear of disrupting the integrity of the hymen (28.6%), fear of risks associated with the procedure (25.7%).• Only 25.5% of Muslims would accept FP compared to 52.5% Christians.• The acceptance rate was 21.4% if the chances of infertility were less than 20%.• Lack of awareness about the complications of cancer treatment related to fertility.• Religion (Muslims are less likely to accept FP).• Lack of patient education from the healthcare providers.• Lack of access to proper services and facilities.• Fear of disrupting virginity in young single women.• Fear of complications of FP-related treatment and procedures.Vesali et al., 2019 [20]IranSpecialists in radiation oncology and hematology(N = 103)Cross-sectional study• Self-perception of knowledge, attitudes, and practices regarding FP• Participants had moderate knowledge about gonadotropin-releasing hormone agonist therapy for ovarian suppression and sperm cryopreservation.• Participants had little knowledge about oocyte tissue, oocyte, embryo, and testicular tissues, cryopreservation, and ovarian transposition.• Most participants knew about existing FP centers, with females having more knowledge than males.• Most oncologists felt that FP was important and would recommend it regardless of the gender and parental status of the patient.• Less than 17% provided patients with written information about FP.• Many referred patients to reproductive specialists.• Limited knowledge among oncologists.• Oncologists are unable to provide objective information to patients about FP.Abdel-Razeq et al., 2020 [21]JordanWomen 44 years or younger with invasive breast carcinoma, and on treatment with anthracycline and/or adjuvant chemotherapy(N = 94)Observational study• Rate of fertility counseling• Premature Ovarian Failure• 14.1% were not counseled by oncologists about amenorrhea as a complication of chemotherapy.• 85.9% were counseled by oncologists about amenorrhea as a complication of chemotherapy.• 54.3% developed long-term amenorrhea.• 40.2% were planning to have children post-treatment.• 46.7% stated they would use OF services.• Inconsistent counseling and patient education about fertility before starting cancer treatmentAbdel-Razeq et al., 2020 [22]JordanYoung male patients newly diagnosed with cancer and planned to start curative chemotherapy (N = 186)Survey• Desire to have children, discussion of risk of infertility with medical team, and recommendation for sperm banking.• 75% received fertility counseling from their oncologist before treatment.• Counseling rates were higher among patients with early-stage diseases and those younger.• Sperm banking was performed for only 33.1% and rates were higher among single and highly educated clients.• Wanting children in the future was associated with high banking rates.• Not informing about the risk of infertility and the availability of sperm banking services was associated with high rates of failure of sperm banking.• Fear of delay of cancer treatment (20%).• Cost of service• Confidentiality• Inconsistent counseling and patient education about fertility before starting cancer treatment.• Cost of onco-fertility care• Patients lack knowledge.• Patient’s fear of complications related to fertility treatment.• Patients fear delaying cancer treatment.• Confidentiality• Oncologist biases related to age, patient education, and parental status.Assi et al., 2020 [23]LebanonWomen treated for breast cancer (without metastatic disease, without known infertility upon cancer diagnosis or later)(N = 39)Retrospective study• Discussion of the risk of infertility with primary oncologists before initiation of therapy.• Awareness and use of FP techniques.•• 84.6% already had children.• 30.8% wanted more children at the time of diagnosis.• Only 20.1% discussed fertility with the primary treating oncologist before treatment initiation, and 44.4% felt discussion was sufficient.• 35.9% were aware of the availability of FP techniques before starting therapy.• 66.7% were aware of FP techniques.• Of the twelve women who wanted more children, 25% achieved pregnancy.• Failure of the primary oncologist to sufficiently discuss fertility issues before initiating cancer therapy.• Lack of awareness about FP among patientsOmranipour et al., 2020 [24]IranWomen with breast cancer (N = 146)Not stated• Factors impacting participation in FP.• OF and FP were presented to all patients.• 37.7% requested OF related counseling before the initiation of therapy.• Reasons for not requesting service: did not need more children, disease stages, or treatment plans.• 18.2% felt that FP could delay cancer treatment.• Cost of FP.• Perceived delay in initiating cancer treatment due to FP treatments and procedures.• Cost of FP.Omani-Samai & Vesali, 2020 [25]IranGynecologists and embryologists (N = 277)Survey• Knowledge, practices, and attitudes about FP• Availability of services and guidelines about FP• All had above median knowledge and attitude about fertility preservation.• > 90% needed more information on fertility preservation techniques.• 64%−56% did not know that there were no guidelines for fertility preservation in the country.• The age of the patient influenced the reason for discussing FP.• Most participants regard FP as important and would recommend it to cancer patients.• > 97% indicated a need for a fertility counselor in cancer treatment centers.• Less than 68% provided written information about FP.• > 92% referred patients to FP centers.• Gynecologists and embryologists have inadequate information or confidence in information about FP.• Lack of guidelines for FP.• Healthcare providers’ biases related to age.• Lack of fertility counselors in cancer treatment centers.• Inconsistent counseling and patient education about fertility before starting cancer treatment.Omani-Samani et al., 2021 [26]IranCancer patients recently (> 6months) diagnosed and undergoing cancer treatments.(N = 384)Survey• Knowledge and attitudes towards FP• Most patients were not aware of available FP treatment options or methods.• > 88.4% did not know about IVF with embryo cryopreservation.• 90% of parents and 89% of adult cancer patients were not aware of sperm and oocyte cryopreservation.• Only 14.1% of patients < 18 years were aware of the fertility risks of cancer treatment.• Most parents and patients < 18 years did not know about centers providing FP services.• Most participants felt that FP was important.• Most parents (72.7%) and patients (90%) preferred to start cancer treatment rather than start FP after cancer diagnosis.• Oncologists did not refer them to reproductive specialists for FP.• Lack of access to FP services.• Patient’s lack of knowledge.• Patient and parent preference of cancer treatment Vs FP.• Fear of delaying cancer treatment.• Failure to refer patients to a reproductive or fertility specialist.El-Said Mansour & Hassan, 2021 [27]EgyptOncology nurses (N = 61)A quasi-experimental (pre-test and post-test) design• Knowledge and attitudes about FP•• The majority had poor knowledge about the cause of infertility, FP, and FP methods before the education intervention.• Participants had low confidence, awareness, and high perceived barriers to FP.• Education intervention significantly improved participants’ knowledge and attitudes, and reduced perceived barriers to FP.• Oncology nurses have limited knowledge about FP.• Oncology nurses have a suboptimal attitude about FP.• Oncology nurses perceive multiple barriers to FP.Abusanad et al., 2022 [28]Saudi ArabiaCancer patient in the day care unit (N = 135)Descriptive cross-sectional study• Awareness, knowledge, and behavior related to OF support• 56.3% expressed a desire to have children.• 8.1% received psychological support.• 57.3% of females were advised about post-cancer therapy amenorrhea.• 70.4% had sufficient knowledge about treatment-related infertility and FP.• Male gender, high income, and education were associated with more knowledge.• 62.2% were not offered fertility counseling by physicians.• Patients who were male and with high incomes received more counseling.• Other reasons for not undergoing FP: not having information, not being discussed by physicians, cost, fear of delaying cancer treatment, and lack of family support.• Religious and cultural reasons.• Inconsistent counseling and patient education about fertility before starting cancer treatment.• Lack of psychological support from healthcare providers.• Lack of information and patient teaching from healthcare providers.• Provider biases related to the gender and social status of the patient.• Cost of FP.• Fear of delaying cancer treatment.• Lack of family support• Religion• Patient cultural limitations.Kassem et al., 2022 [29]9 Arab countries located in North Africa and Greater Middle East170 OncologistSurvey• Knowledge, attitude, and behaviors regarding OF in female cancer patients• Only 52.4% refer to clinical practice guidelines about FP in cancer patients.• 71.8% did not have a prepared infertility consent offered to patients before the start of treatment.• Only 10% had a fertility counseling clinic in their hospital.• 56.5% did not report the presence of dedicated FP services.• Barriers: fear of delaying active cancer treatment, lack of advanced FP techniques in most centers, cost, religion, and culture of patients.• Legal barriers to providing FP in young female cancer patients.• Inadequate physician awareness and training• Limited utilization of evidence-based clinical practice guidelines.• Lack of an infertility consent process or full disclosure before starting cancer therapy.• Lack of access to fertility counseling services for cancer patients.• Inadequate access to dedicated FP services for cancer patients.• Cost• Legal barriers• Religion of the patient• Culture of the patient• Fear of delaying cancer treatment• Lack of physician awareness• Lack of adequate training among physicians• Unavailability of advanced FP techniquesIbrahim et al., 2023 [30]EgyptAdult cancer patients and parents of young cancer patients, Females aged 20 to 25 years diagnosed with gynecological cancer and soon to receive cancer therapy (N = 374)Quasi-experimental (pretest and posttest) design• Knowledge and attitude about cryopreservation• Before intervention, 71.4% had poor knowledge.• After the education package intervention, 87.5% had good knowledge about cryopreservation.• Only 24.5% had a positive attitude towards cryopreservation before the intervention.• 89% had a positive attitude after the intervention.• Poor knowledge and negative attitudes of patients about cryopreservationFarhat et al., 2023 [31]Saudi ArabiaMedical student in the final year of their studies (N = 320)Cross-sectional study• Knowledge and attitudes regarding FP• 78.6% had good knowledge about the side effects of cancer treatment on fertility.• Only 46% knew about the availability of FP services in their states.• Less than 36% knew about testicular tissue preservation, ovarian tissue preservation, and ovarian transposition.• Perceived barriers to FP were cost, shortage of information, and lack of access to services.• Perceived FP as important (63.6%).• Perceived FP as successful (14.6%).• Perceived cancer treatment as a priority (49%) compared to FP (24.4%).• The curriculum used to train medical students does not give enough emphasis on FP for cancer patients.• Cost of FP.• Shortage of information about FP.• Lack of access to services• Attitudes about the priority of cancer treatments Vs FP.Al Ghaithi et al., 2023 [32]OmanOncologists treating cancer patients (N = 34)Cross-sectional study• Knowledge, current practice, barriers to FP, perceptions, and attitudes towards FP• Were knowledgeable about sperm (62%), GnRH agonists (47%), ovarian tissue (35.5%), and oocyte (27%) cryopreservation.• 94% needed to know more about FP.• 71% usually or always check with the patients about future fertility plans.• Only 12% provided written information about FP.• 27% referred to patients for discussions with fertility specialists or reproductive endocrinologists.• 65% consider 40 years the upper age limit to give FP counseling.• 59% felt treating primary cancer is more important than FP.• Lack of infrastructure for fertility services (82%).• Limited knowledge about FP options (59%).• Having emotional distress hinders the initiation of FP discussion (71%).• The parent status of the patient influences the decision to start FP discussion.• Knowledge level of oncologists about FP.• Lack of written information for patients.• Bias of the oncologist related to age and gender.• Lack of psychological support for patients.Arafa et al., 2023 [33]Saudi ArabiaMale Oncologists(N = 117)Cross-Sectional survey• Attitudes and practices regarding FP• Radiation oncologists had higher knowledge compared to surgical and medical oncologists.• 83.3% perceive FP as especially important.• 63.3% knew where to send patients for cryopreservation.• 84.4% knew the correct timing for sending patients to do cryopreservation.• 76% knew intra-cytoplasmic sperm injection.• Only 43.3% routinely discuss cryopreservation with their patients.• 50% rarely bring up the topic of cryopreservation when talking to patients.• Only 22% refer their patients to fertility specialists.• Most oncologists (76.6%) were familiar with oocyte cryopreservation. And ovarian suppression (34.3%).• The causes of the non-discussion of cryopreservation were fear of delaying cancer therapy (58%), and concern about future children of cancer patients (31%), and belief that FP is a complicated process.• 42% knew that oocyte preservation was available in the health facility.• Suboptimal knowledge among some oncology specialists.• Failure of oncologist to discuss cryopreservation with patients during clinical practice.• Failure to refer patients to fertility specialists.• Beliefs and fears of the oncologist about fertility preservation treatment and future children of cancer patients.• Fear of delaying cancer treatment.Saber Nady Mohammed et al., 2024 [34]EgyptYoung women with cancer and planning to start cancer treatment.(N = 100)Quasi-experimental design (2-group)• Barriers to FP discussion, Knowledge about FP, and decisional conflict• Lack of reproductive services (70% study Vs 62% control).• Proximity of reproductive health clinic (68%).• Poor communication about future fertility (66%).• Financial strain (66% study Vs 62% control.• Delaying cancer therapy 68% Vs 60%).• Inadequate time for counseling (56% Vs 56%).• Insufficient information about FP.• Poor knowledge regarding FP.• Patient-centered decision counseling improved FP knowledge and reduced decision-making conflict about engagement in FP.• Lack of access to reproductive health services.• Poor communication from healthcare providers.• Cost• Inadequate counseling services related to FP.• Poor knowledge about FPGhaemi et al., 2024 [35]IranPhysicians (obstetricians, gynecologists, surgeons, radiotherapists, nuclear medicine specialists, and pediatricians)(N = 423)Cross-sectional study• OF knowledge, attitude, and current practices• Only 17.2% had attended theoretical courses on OF.• 64.1% acknowledge the importance of education about OF.• Only 55.1% had access to psychologists during fertility treatments.• 65.5% did not follow any specific guidelines.• Only 23.9% reported that FP strategies were included in their routine treatment.• Lack of awareness about cost and insurance coverage for FP techniques.• 65% lacked knowledge about legal issues related to the FP of cancer patients.• 99% acknowledged the presence of legal barriers.• 99% reported religious and cultural barriers to fertility maintenance in cancer patients.• Lack of training curriculum emphasis on OF.• Lack of access to psychological support services.• Limited utilization of evidence-based clinical practice guidelines• Cost• Lack of awareness about legal issues related to FP.• Patient culture• Patient religionGabr et al., 2025 [36]Saudi ArabiaWomen with cancer and that possess an internet connected smart phone.(N = 100)Quasi-experimental (pre-post design after social media platforms-based nursing education about cryopreservation)• Knowledge, attitude, and practices about FP before and after the education intervention.• 100% had not received prior instruction about cryopreservation.• 97% had poor knowledge before the intervention.• 95% had satisfactory knowledge after the intervention.• 70% had a negative attitude before the intervention.• 85% had positive attitudes after the intervention.• Poor knowledge and negative attitudes of patients about cryopreservation• Lack of patient teaching about FP.Sbaity et al., 2025 [37]LebanonWomen aged 18 to 42 diagnosed with non-metastatic breast cancer or lymphoma (N = 123)Prospective cohort study• Knowledge and attitude, fertility concerns, psychological aspects, and QOL• 58.8% acknowledged the importance of FP.• 56.1% of the patients opted to receive official fertility counseling.• 73.5% were willing to undergo FP, with 40 patients being primarily driven by a desire for future children and 10 patients driven by external influence.• 45.4% of the patients expressed a wish for FP.• Younger nulliparous females, females with higher education, had a greater desire for FP counselling.• In oncologists’ discussions, such as the ability to become pregnant, menstrual periods, potential menopause, and the impact of cancer treatment on fertility, patients reported higher satisfaction levels.• Underappreciation (either did not prioritize their fertility or already had children and were satisfied)• Cost of FP• Fear of treatment delay• Misconceptions (not trusting the process or harboring disproportionate concerns)• Lower educational status• Older, married with children.• Concern about the complications related to the procedure and the treatment.• Lack of informationLamyian et al., 2025 [38]IranHealthcare providers (midwives, nurses, counselors, psychologists, reproductive biologists, surgeons, oncologists)- (N = 186) and Breast cancer patients (N = 2)Qualitative study• Provision of FP to breast cancer patients• One patient had undergone FP.• Lack of adequate access in various parts of the country• Prohibitive costs• Lack of insurance coverage• Rushing to start cancer treatment• Priority is to save life from cancer.• Lack of information to patients• Lack of adequate access• Cost• Fear of delaying cancer treatment• Inadequate information to patientsFP, fertility preservation; OF, oncofertility Table 1Summary of the studies included in the reviewAuthorCountryParticipantsStudy designStudy outcomes or measuresMain findingsIdentified barriersRashed et al., 2018 [17]EgyptSingle females (20 to 25 years of age) diagnosed with cancer and going to receive cancer treatment.(N = 100)Quasi-experimental (pre-post evaluation after cryopreservation counseling)• Knowledge and attitude toward cryopreservation• Knowledge about cryopreservation was poor (73%) and improved to good (78%) after counseling.• Attitudes of the patients were negative (63%) and improved to positive (82%) after the counseling.• Poor knowledge and negative attitudes of patients about cryopreservationRashidi et al., 2018 [18]IranFemale cancer patients are referred to the infertility center.(N = 77)Retrospective study• Desire FP• The cause of refusing FP• Thirty-eight people were recruited for FP.• Of the thirty-eight patients recruited for FP, four had received chemotherapy before referring.• One patient had radiotherapy before the referral.• Other reasons for not getting FP: cost, fear of delaying cancer treatment, fear of ovarian stimulation complications.• Inconsistent counseling and patient education about fertility before starting cancer treatment.• Cost of onco-fertility care• Patients lack knowledge.• Patient’s fear of complications related to fertility treatment.• Patient’s fear of delaying cancer treatmentKhalife et al., 2019 [19]LebanonParents of Female patients (ages 11–20 years) receiving cancer treatment(N = 70)Survey• Knowledge of the effect of cancer treatment on fertility, FP options, and readiness for FP.•• Only 44.3% were aware of the adverse effects of cancer treatment on fertility before initiation of treatment.• Only 28.6% were concerned about the effect of treatment on their daughter’s fertility.• Patients with higher levels of education were concerned about fertility-related issues.• 85.6% were not offered the option of FP.• Reason for not discussing FP: difficulty finding proper facilities (22.8%), fear of disrupting the integrity of the hymen (28.6%), fear of risks associated with the procedure (25.7%).• Only 25.5% of Muslims would accept FP compared to 52.5% Christians.• The acceptance rate was 21.4% if the chances of infertility were less than 20%.• Lack of awareness about the complications of cancer treatment related to fertility.• Religion (Muslims are less likely to accept FP).• Lack of patient education from the healthcare providers.• Lack of access to proper services and facilities.• Fear of disrupting virginity in young single women.• Fear of complications of FP-related treatment and procedures.Vesali et al., 2019 [20]IranSpecialists in radiation oncology and hematology(N = 103)Cross-sectional study• Self-perception of knowledge, attitudes, and practices regarding FP• Participants had moderate knowledge about gonadotropin-releasing hormone agonist therapy for ovarian suppression and sperm cryopreservation.• Participants had little knowledge about oocyte tissue, oocyte, embryo, and testicular tissues, cryopreservation, and ovarian transposition.• Most participants knew about existing FP centers, with females having more knowledge than males.• Most oncologists felt that FP was important and would recommend it regardless of the gender and parental status of the patient.• Less than 17% provided patients with written information about FP.• Many referred patients to reproductive specialists.• Limited knowledge among oncologists.• Oncologists are unable to provide objective information to patients about FP.Abdel-Razeq et al., 2020 [21]JordanWomen 44 years or younger with invasive breast carcinoma, and on treatment with anthracycline and/or adjuvant chemotherapy(N = 94)Observational study• Rate of fertility counseling• Premature Ovarian Failure• 14.1% were not counseled by oncologists about amenorrhea as a complication of chemotherapy.• 85.9% were counseled by oncologists about amenorrhea as a complication of chemotherapy.• 54.3% developed long-term amenorrhea.• 40.2% were planning to have children post-treatment.• 46.7% stated they would use OF services.• Inconsistent counseling and patient education about fertility before starting cancer treatmentAbdel-Razeq et al., 2020 [22]JordanYoung male patients newly diagnosed with cancer and planned to start curative chemotherapy (N = 186)Survey• Desire to have children, discussion of risk of infertility with medical team, and recommendation for sperm banking.• 75% received fertility counseling from their oncologist before treatment.• Counseling rates were higher among patients with early-stage diseases and those younger.• Sperm banking was performed for only 33.1% and rates were higher among single and highly educated clients.• Wanting children in the future was associated with high banking rates.• Not informing about the risk of infertility and the availability of sperm banking services was associated with high rates of failure of sperm banking.• Fear of delay of cancer treatment (20%).• Cost of service• Confidentiality• Inconsistent counseling and patient education about fertility before starting cancer treatment.• Cost of onco-fertility care• Patients lack knowledge.• Patient’s fear of complications related to fertility treatment.• Patients fear delaying cancer treatment.• Confidentiality• Oncologist biases related to age, patient education, and parental status.Assi et al., 2020 [23]LebanonWomen treated for breast cancer (without metastatic disease, without known infertility upon cancer diagnosis or later)(N = 39)Retrospective study• Discussion of the risk of infertility with primary oncologists before initiation of therapy.• Awareness and use of FP techniques.•• 84.6% already had children.• 30.8% wanted more children at the time of diagnosis.• Only 20.1% discussed fertility with the primary treating oncologist before treatment initiation, and 44.4% felt discussion was sufficient.• 35.9% were aware of the availability of FP techniques before starting therapy.• 66.7% were aware of FP techniques.• Of the twelve women who wanted more children, 25% achieved pregnancy.• Failure of the primary oncologist to sufficiently discuss fertility issues before initiating cancer therapy.• Lack of awareness about FP among patientsOmranipour et al., 2020 [24]IranWomen with breast cancer (N = 146)Not stated• Factors impacting participation in FP.• OF and FP were presented to all patients.• 37.7% requested OF related counseling before the initiation of therapy.• Reasons for not requesting service: did not need more children, disease stages, or treatment plans.• 18.2% felt that FP could delay cancer treatment.• Cost of FP.• Perceived delay in initiating cancer treatment due to FP treatments and procedures.• Cost of FP.Omani-Samai & Vesali, 2020 [25]IranGynecologists and embryologists (N = 277)Survey• Knowledge, practices, and attitudes about FP• Availability of services and guidelines about FP• All had above median knowledge and attitude about fertility preservation.• > 90% needed more information on fertility preservation techniques.• 64%−56% did not know that there were no guidelines for fertility preservation in the country.• The age of the patient influenced the reason for discussing FP.• Most participants regard FP as important and would recommend it to cancer patients.• > 97% indicated a need for a fertility counselor in cancer treatment centers.• Less than 68% provided written information about FP.• > 92% referred patients to FP centers.• Gynecologists and embryologists have inadequate information or confidence in information about FP.• Lack of guidelines for FP.• Healthcare providers’ biases related to age.• Lack of fertility counselors in cancer treatment centers.• Inconsistent counseling and patient education about fertility before starting cancer treatment.Omani-Samani et al., 2021 [26]IranCancer patients recently (> 6months) diagnosed and undergoing cancer treatments.(N = 384)Survey• Knowledge and attitudes towards FP• Most patients were not aware of available FP treatment options or methods.• > 88.4% did not know about IVF with embryo cryopreservation.• 90% of parents and 89% of adult cancer patients were not aware of sperm and oocyte cryopreservation.• Only 14.1% of patients < 18 years were aware of the fertility risks of cancer treatment.• Most parents and patients < 18 years did not know about centers providing FP services.• Most participants felt that FP was important.• Most parents (72.7%) and patients (90%) preferred to start cancer treatment rather than start FP after cancer diagnosis.• Oncologists did not refer them to reproductive specialists for FP.• Lack of access to FP services.• Patient’s lack of knowledge.• Patient and parent preference of cancer treatment Vs FP.• Fear of delaying cancer treatment.• Failure to refer patients to a reproductive or fertility specialist.El-Said Mansour & Hassan, 2021 [27]EgyptOncology nurses (N = 61)A quasi-experimental (pre-test and post-test) design• Knowledge and attitudes about FP•• The majority had poor knowledge about the cause of infertility, FP, and FP methods before the education intervention.• Participants had low confidence, awareness, and high perceived barriers to FP.• Education intervention significantly improved participants’ knowledge and attitudes, and reduced perceived barriers to FP.• Oncology nurses have limited knowledge about FP.• Oncology nurses have a suboptimal attitude about FP.• Oncology nurses perceive multiple barriers to FP.Abusanad et al., 2022 [28]Saudi ArabiaCancer patient in the day care unit (N = 135)Descriptive cross-sectional study• Awareness, knowledge, and behavior related to OF support• 56.3% expressed a desire to have children.• 8.1% received psychological support.• 57.3% of females were advised about post-cancer therapy amenorrhea.• 70.4% had sufficient knowledge about treatment-related infertility and FP.• Male gender, high income, and education were associated with more knowledge.• 62.2% were not offered fertility counseling by physicians.• Patients who were male and with high incomes received more counseling.• Other reasons for not undergoing FP: not having information, not being discussed by physicians, cost, fear of delaying cancer treatment, and lack of family support.• Religious and cultural reasons.• Inconsistent counseling and patient education about fertility before starting cancer treatment.• Lack of psychological support from healthcare providers.• Lack of information and patient teaching from healthcare providers.• Provider biases related to the gender and social status of the patient.• Cost of FP.• Fear of delaying cancer treatment.• Lack of family support• Religion• Patient cultural limitations.Kassem et al., 2022 [29]9 Arab countries located in North Africa and Greater Middle East170 OncologistSurvey• Knowledge, attitude, and behaviors regarding OF in female cancer patients• Only 52.4% refer to clinical practice guidelines about FP in cancer patients.• 71.8% did not have a prepared infertility consent offered to patients before the start of treatment.• Only 10% had a fertility counseling clinic in their hospital.• 56.5% did not report the presence of dedicated FP services.• Barriers: fear of delaying active cancer treatment, lack of advanced FP techniques in most centers, cost, religion, and culture of patients.• Legal barriers to providing FP in young female cancer patients.• Inadequate physician awareness and training• Limited utilization of evidence-based clinical practice guidelines.• Lack of an infertility consent process or full disclosure before starting cancer therapy.• Lack of access to fertility counseling services for cancer patients.• Inadequate access to dedicated FP services for cancer patients.• Cost• Legal barriers• Religion of the patient• Culture of the patient• Fear of delaying cancer treatment• Lack of physician awareness• Lack of adequate training among physicians• Unavailability of advanced FP techniquesIbrahim et al., 2023 [30]EgyptAdult cancer patients and parents of young cancer patients, Females aged 20 to 25 years diagnosed with gynecological cancer and soon to receive cancer therapy (N = 374)Quasi-experimental (pretest and posttest) design• Knowledge and attitude about cryopreservation• Before intervention, 71.4% had poor knowledge.• After the education package intervention, 87.5% had good knowledge about cryopreservation.• Only 24.5% had a positive attitude towards cryopreservation before the intervention.• 89% had a positive attitude after the intervention.• Poor knowledge and negative attitudes of patients about cryopreservationFarhat et al., 2023 [31]Saudi ArabiaMedical student in the final year of their studies (N = 320)Cross-sectional study• Knowledge and attitudes regarding FP• 78.6% had good knowledge about the side effects of cancer treatment on fertility.• Only 46% knew about the availability of FP services in their states.• Less than 36% knew about testicular tissue preservation, ovarian tissue preservation, and ovarian transposition.• Perceived barriers to FP were cost, shortage of information, and lack of access to services.• Perceived FP as important (63.6%).• Perceived FP as successful (14.6%).• Perceived cancer treatment as a priority (49%) compared to FP (24.4%).• The curriculum used to train medical students does not give enough emphasis on FP for cancer patients.• Cost of FP.• Shortage of information about FP.• Lack of access to services• Attitudes about the priority of cancer treatments Vs FP.Al Ghaithi et al., 2023 [32]OmanOncologists treating cancer patients (N = 34)Cross-sectional study• Knowledge, current practice, barriers to FP, perceptions, and attitudes towards FP• Were knowledgeable about sperm (62%), GnRH agonists (47%), ovarian tissue (35.5%), and oocyte (27%) cryopreservation.• 94% needed to know more about FP.• 71% usually or always check with the patients about future fertility plans.• Only 12% provided written information about FP.• 27% referred to patients for discussions with fertility specialists or reproductive endocrinologists.• 65% consider 40 years the upper age limit to give FP counseling.• 59% felt treating primary cancer is more important than FP.• Lack of infrastructure for fertility services (82%).• Limited knowledge about FP options (59%).• Having emotional distress hinders the initiation of FP discussion (71%).• The parent status of the patient influences the decision to start FP discussion.• Knowledge level of oncologists about FP.• Lack of written information for patients.• Bias of the oncologist related to age and gender.• Lack of psychological support for patients.Arafa et al., 2023 [33]Saudi ArabiaMale Oncologists(N = 117)Cross-Sectional survey• Attitudes and practices regarding FP• Radiation oncologists had higher knowledge compared to surgical and medical oncologists.• 83.3% perceive FP as especially important.• 63.3% knew where to send patients for cryopreservation.• 84.4% knew the correct timing for sending patients to do cryopreservation.• 76% knew intra-cytoplasmic sperm injection.• Only 43.3% routinely discuss cryopreservation with their patients.• 50% rarely bring up the topic of cryopreservation when talking to patients.• Only 22% refer their patients to fertility specialists.• Most oncologists (76.6%) were familiar with oocyte cryopreservation. And ovarian suppression (34.3%).• The causes of the non-discussion of cryopreservation were fear of delaying cancer therapy (58%), and concern about future children of cancer patients (31%), and belief that FP is a complicated process.• 42% knew that oocyte preservation was available in the health facility.• Suboptimal knowledge among some oncology specialists.• Failure of oncologist to discuss cryopreservation with patients during clinical practice.• Failure to refer patients to fertility specialists.• Beliefs and fears of the oncologist about fertility preservation treatment and future children of cancer patients.• Fear of delaying cancer treatment.Saber Nady Mohammed et al., 2024 [34]EgyptYoung women with cancer and planning to start cancer treatment.(N = 100)Quasi-experimental design (2-group)• Barriers to FP discussion, Knowledge about FP, and decisional conflict• Lack of reproductive services (70% study Vs 62% control).• Proximity of reproductive health clinic (68%).• Poor communication about future fertility (66%).• Financial strain (66% study Vs 62% control.• Delaying cancer therapy 68% Vs 60%).• Inadequate time for counseling (56% Vs 56%).• Insufficient information about FP.• Poor knowledge regarding FP.• Patient-centered decision counseling improved FP knowledge and reduced decision-making conflict about engagement in FP.• Lack of access to reproductive health services.• Poor communication from healthcare providers.• Cost• Inadequate counseling services related to FP.• Poor knowledge about FPGhaemi et al., 2024 [35]IranPhysicians (obstetricians, gynecologists, surgeons, radiotherapists, nuclear medicine specialists, and pediatricians)(N = 423)Cross-sectional study• OF knowledge, attitude, and current practices• Only 17.2% had attended theoretical courses on OF.• 64.1% acknowledge the importance of education about OF.• Only 55.1% had access to psychologists during fertility treatments.• 65.5% did not follow any specific guidelines.• Only 23.9% reported that FP strategies were included in their routine treatment.• Lack of awareness about cost and insurance coverage for FP techniques.• 65% lacked knowledge about legal issues related to the FP of cancer patients.• 99% acknowledged the presence of legal barriers.• 99% reported religious and cultural barriers to fertility maintenance in cancer patients.• Lack of training curriculum emphasis on OF.• Lack of access to psychological support services.• Limited utilization of evidence-based clinical practice guidelines• Cost• Lack of awareness about legal issues related to FP.• Patient culture• Patient religionGabr et al., 2025 [36]Saudi ArabiaWomen with cancer and that possess an internet connected smart phone.(N = 100)Quasi-experimental (pre-post design after social media platforms-based nursing education about cryopreservation)• Knowledge, attitude, and practices about FP before and after the education intervention.• 100% had not received prior instruction about cryopreservation.• 97% had poor knowledge before the intervention.• 95% had satisfactory knowledge after the intervention.• 70% had a negative attitude before the intervention.• 85% had positive attitudes after the intervention.• Poor knowledge and negative attitudes of patients about cryopreservation• Lack of patient teaching about FP.Sbaity et al., 2025 [37]LebanonWomen aged 18 to 42 diagnosed with non-metastatic breast cancer or lymphoma (N = 123)Prospective cohort study• Knowledge and attitude, fertility concerns, psychological aspects, and QOL• 58.8% acknowledged the importance of FP.• 56.1% of the patients opted to receive official fertility counseling.• 73.5% were willing to undergo FP, with 40 patients being primarily driven by a desire for future children and 10 patients driven by external influence.• 45.4% of the patients expressed a wish for FP.• Younger nulliparous females, females with higher education, had a greater desire for FP counselling.• In oncologists’ discussions, such as the ability to become pregnant, menstrual periods, potential menopause, and the impact of cancer treatment on fertility, patients reported higher satisfaction levels.• Underappreciation (either did not prioritize their fertility or already had children and were satisfied)• Cost of FP• Fear of treatment delay• Misconceptions (not trusting the process or harboring disproportionate concerns)• Lower educational status• Older, married with children.• Concern about the complications related to the procedure and the treatment.• Lack of informationLamyian et al., 2025 [38]IranHealthcare providers (midwives, nurses, counselors, psychologists, reproductive biologists, surgeons, oncologists)- (N = 186) and Breast cancer patients (N = 2)Qualitative study• Provision of FP to breast cancer patients• One patient had undergone FP.• Lack of adequate access in various parts of the country• Prohibitive costs• Lack of insurance coverage• Rushing to start cancer treatment• Priority is to save life from cancer.• Lack of information to patients• Lack of adequate access• Cost• Fear of delaying cancer treatment• Inadequate information to patientsFP, fertility preservation; OF, oncofertility Summary of the studies included in the review Single females (20 to 25 years of age) diagnosed with cancer and going to receive cancer treatment. (N = 100) • Knowledge about cryopreservation was poor (73%) and improved to good (78%) after counseling. • Attitudes of the patients were negative (63%) and improved to positive (82%) after the counseling. Female cancer patients are referred to the infertility center. (N = 77) • Desire FP • The cause of refusing FP • Thirty-eight people were recruited for FP. • Of the thirty-eight patients recruited for FP, four had received chemotherapy before referring. • One patient had radiotherapy before the referral. • Other reasons for not getting FP: cost, fear of delaying cancer treatment, fear of ovarian stimulation complications. • Inconsistent counseling and patient education about fertility before starting cancer treatment. • Cost of onco-fertility care • Patients lack knowledge. • Patient’s fear of complications related to fertility treatment. • Patient’s fear of delaying cancer treatment Parents of Female patients (ages 11–20 years) receiving cancer treatment (N = 70) • Only 44.3% were aware of the adverse effects of cancer treatment on fertility before initiation of treatment. • Only 28.6% were concerned about the effect of treatment on their daughter’s fertility. • Patients with higher levels of education were concerned about fertility-related issues. • 85.6% were not offered the option of FP. • Reason for not discussing FP: difficulty finding proper facilities (22.8%), fear of disrupting the integrity of the hymen (28.6%), fear of risks associated with the procedure (25.7%). • Only 25.5% of Muslims would accept FP compared to 52.5% Christians. • The acceptance rate was 21.4% if the chances of infertility were less than 20%. • Lack of awareness about the complications of cancer treatment related to fertility. • Religion (Muslims are less likely to accept FP). • Lack of patient education from the healthcare providers. • Lack of access to proper services and facilities. • Fear of disrupting virginity in young single women. • Fear of complications of FP-related treatment and procedures. Specialists in radiation oncology and hematology (N = 103) • Participants had moderate knowledge about gonadotropin-releasing hormone agonist therapy for ovarian suppression and sperm cryopreservation. • Participants had little knowledge about oocyte tissue, oocyte, embryo, and testicular tissues, cryopreservation, and ovarian transposition. • Most participants knew about existing FP centers, with females having more knowledge than males. • Most oncologists felt that FP was important and would recommend it regardless of the gender and parental status of the patient. • Less than 17% provided patients with written information about FP. • Many referred patients to reproductive specialists. • Limited knowledge among oncologists. • Oncologists are unable to provide objective information to patients about FP. Women 44 years or younger with invasive breast carcinoma, and on treatment with anthracycline and/or adjuvant chemotherapy (N = 94) • Rate of fertility counseling • Premature Ovarian Failure • 14.1% were not counseled by oncologists about amenorrhea as a complication of chemotherapy. • 85.9% were counseled by oncologists about amenorrhea as a complication of chemotherapy. • 54.3% developed long-term amenorrhea. • 40.2% were planning to have children post-treatment. • 46.7% stated they would use OF services. • 75% received fertility counseling from their oncologist before treatment. • Counseling rates were higher among patients with early-stage diseases and those younger. • Sperm banking was performed for only 33.1% and rates were higher among single and highly educated clients. • Wanting children in the future was associated with high banking rates. • Not informing about the risk of infertility and the availability of sperm banking services was associated with high rates of failure of sperm banking. • Fear of delay of cancer treatment (20%). • Cost of service • Confidentiality • Inconsistent counseling and patient education about fertility before starting cancer treatment. • Cost of onco-fertility care • Patients lack knowledge. • Patient’s fear of complications related to fertility treatment. • Patients fear delaying cancer treatment. • Confidentiality • Oncologist biases related to age, patient education, and parental status. Women treated for breast cancer (without metastatic disease, without known infertility upon cancer diagnosis or later) (N = 39) • Discussion of the risk of infertility with primary oncologists before initiation of therapy. • Awareness and use of FP techniques.• • 84.6% already had children. • 30.8% wanted more children at the time of diagnosis. • Only 20.1% discussed fertility with the primary treating oncologist before treatment initiation, and 44.4% felt discussion was sufficient. • 35.9% were aware of the availability of FP techniques before starting therapy. • 66.7% were aware of FP techniques. • Of the twelve women who wanted more children, 25% achieved pregnancy. • Failure of the primary oncologist to sufficiently discuss fertility issues before initiating cancer therapy. • Lack of awareness about FP among patients • OF and FP were presented to all patients. • 37.7% requested OF related counseling before the initiation of therapy. • Reasons for not requesting service: did not need more children, disease stages, or treatment plans. • 18.2% felt that FP could delay cancer treatment. • Cost of FP. • Perceived delay in initiating cancer treatment due to FP treatments and procedures. • Cost of FP. • Knowledge, practices, and attitudes about FP • Availability of services and guidelines about FP • All had above median knowledge and attitude about fertility preservation. • > 90% needed more information on fertility preservation techniques. • 64%−56% did not know that there were no guidelines for fertility preservation in the country. • The age of the patient influenced the reason for discussing FP. • Most participants regard FP as important and would recommend it to cancer patients. • > 97% indicated a need for a fertility counselor in cancer treatment centers. • Less than 68% provided written information about FP. • > 92% referred patients to FP centers. • Gynecologists and embryologists have inadequate information or confidence in information about FP. • Lack of guidelines for FP. • Healthcare providers’ biases related to age. • Lack of fertility counselors in cancer treatment centers. • Inconsistent counseling and patient education about fertility before starting cancer treatment. Cancer patients recently (> 6months) diagnosed and undergoing cancer treatments. (N = 384) • Most patients were not aware of available FP treatment options or methods. • > 88.4% did not know about IVF with embryo cryopreservation. • 90% of parents and 89% of adult cancer patients were not aware of sperm and oocyte cryopreservation. • Only 14.1% of patients < 18 years were aware of the fertility risks of cancer treatment. • Most parents and patients < 18 years did not know about centers providing FP services. • Most participants felt that FP was important. • Most parents (72.7%) and patients (90%) preferred to start cancer treatment rather than start FP after cancer diagnosis. • Oncologists did not refer them to reproductive specialists for FP. • Lack of access to FP services. • Patient’s lack of knowledge. • Patient and parent preference of cancer treatment Vs FP. • Fear of delaying cancer treatment. • Failure to refer patients to a reproductive or fertility specialist. • The majority had poor knowledge about the cause of infertility, FP, and FP methods before the education intervention. • Participants had low confidence, awareness, and high perceived barriers to FP. • Education intervention significantly improved participants’ knowledge and attitudes, and reduced perceived barriers to FP. • Oncology nurses have limited knowledge about FP. • Oncology nurses have a suboptimal attitude about FP. • Oncology nurses perceive multiple barriers to FP. • 56.3% expressed a desire to have children. • 8.1% received psychological support. • 57.3% of females were advised about post-cancer therapy amenorrhea. • 70.4% had sufficient knowledge about treatment-related infertility and FP. • Male gender, high income, and education were associated with more knowledge. • 62.2% were not offered fertility counseling by physicians. • Patients who were male and with high incomes received more counseling. • Other reasons for not undergoing FP: not having information, not being discussed by physicians, cost, fear of delaying cancer treatment, and lack of family support. • Religious and cultural reasons. • Inconsistent counseling and patient education about fertility before starting cancer treatment. • Lack of psychological support from healthcare providers. • Lack of information and patient teaching from healthcare providers. • Provider biases related to the gender and social status of the patient. • Cost of FP. • Fear of delaying cancer treatment. • Lack of family support • Religion • Patient cultural limitations. • Only 52.4% refer to clinical practice guidelines about FP in cancer patients. • 71.8% did not have a prepared infertility consent offered to patients before the start of treatment. • Only 10% had a fertility counseling clinic in their hospital. • 56.5% did not report the presence of dedicated FP services. • Barriers: fear of delaying active cancer treatment, lack of advanced FP techniques in most centers, cost, religion, and culture of patients. • Legal barriers to providing FP in young female cancer patients. • Inadequate physician awareness and training • Limited utilization of evidence-based clinical practice guidelines. • Lack of an infertility consent process or full disclosure before starting cancer therapy. • Lack of access to fertility counseling services for cancer patients. • Inadequate access to dedicated FP services for cancer patients. • Cost • Legal barriers • Religion of the patient • Culture of the patient • Fear of delaying cancer treatment • Lack of physician awareness • Lack of adequate training among physicians • Unavailability of advanced FP techniques • Before intervention, 71.4% had poor knowledge. • After the education package intervention, 87.5% had good knowledge about cryopreservation. • Only 24.5% had a positive attitude towards cryopreservation before the intervention. • 89% had a positive attitude after the intervention. • 78.6% had good knowledge about the side effects of cancer treatment on fertility. • Only 46% knew about the availability of FP services in their states. • Less than 36% knew about testicular tissue preservation, ovarian tissue preservation, and ovarian transposition. • Perceived barriers to FP were cost, shortage of information, and lack of access to services. • Perceived FP as important (63.6%). • Perceived FP as successful (14.6%). • Perceived cancer treatment as a priority (49%) compared to FP (24.4%). • The curriculum used to train medical students does not give enough emphasis on FP for cancer patients. • Cost of FP. • Shortage of information about FP. • Lack of access to services • Attitudes about the priority of cancer treatments Vs FP. • Were knowledgeable about sperm (62%), GnRH agonists (47%), ovarian tissue (35.5%), and oocyte (27%) cryopreservation. • 94% needed to know more about FP. • 71% usually or always check with the patients about future fertility plans. • Only 12% provided written information about FP. • 27% referred to patients for discussions with fertility specialists or reproductive endocrinologists. • 65% consider 40 years the upper age limit to give FP counseling. • 59% felt treating primary cancer is more important than FP. • Lack of infrastructure for fertility services (82%). • Limited knowledge about FP options (59%). • Having emotional distress hinders the initiation of FP discussion (71%). • The parent status of the patient influences the decision to start FP discussion. • Knowledge level of oncologists about FP. • Lack of written information for patients. • Bias of the oncologist related to age and gender. • Lack of psychological support for patients. Male Oncologists (N = 117) • Radiation oncologists had higher knowledge compared to surgical and medical oncologists. • 83.3% perceive FP as especially important. • 63.3% knew where to send patients for cryopreservation. • 84.4% knew the correct timing for sending patients to do cryopreservation. • 76% knew intra-cytoplasmic sperm injection. • Only 43.3% routinely discuss cryopreservation with their patients. • 50% rarely bring up the topic of cryopreservation when talking to patients. • Only 22% refer their patients to fertility specialists. • Most oncologists (76.6%) were familiar with oocyte cryopreservation. And ovarian suppression (34.3%). • The causes of the non-discussion of cryopreservation were fear of delaying cancer therapy (58%), and concern about future children of cancer patients (31%), and belief that FP is a complicated process. • 42% knew that oocyte preservation was available in the health facility. • Suboptimal knowledge among some oncology specialists. • Failure of oncologist to discuss cryopreservation with patients during clinical practice. • Failure to refer patients to fertility specialists. • Beliefs and fears of the oncologist about fertility preservation treatment and future children of cancer patients. • Fear of delaying cancer treatment. Young women with cancer and planning to start cancer treatment. (N = 100) • Lack of reproductive services (70% study Vs 62% control). • Proximity of reproductive health clinic (68%). • Poor communication about future fertility (66%). • Financial strain (66% study Vs 62% control. • Delaying cancer therapy 68% Vs 60%). • Inadequate time for counseling (56% Vs 56%). • Insufficient information about FP. • Poor knowledge regarding FP. • Patient-centered decision counseling improved FP knowledge and reduced decision-making conflict about engagement in FP. • Lack of access to reproductive health services. • Poor communication from healthcare providers. • Cost • Inadequate counseling services related to FP. • Poor knowledge about FP Physicians (obstetricians, gynecologists, surgeons, radiotherapists, nuclear medicine specialists, and pediatricians) (N = 423) • Only 17.2% had attended theoretical courses on OF. • 64.1% acknowledge the importance of education about OF. • Only 55.1% had access to psychologists during fertility treatments. • 65.5% did not follow any specific guidelines. • Only 23.9% reported that FP strategies were included in their routine treatment. • Lack of awareness about cost and insurance coverage for FP techniques. • 65% lacked knowledge about legal issues related to the FP of cancer patients. • 99% acknowledged the presence of legal barriers. • 99% reported religious and cultural barriers to fertility maintenance in cancer patients. • Lack of training curriculum emphasis on OF. • Lack of access to psychological support services. • Limited utilization of evidence-based clinical practice guidelines • Cost • Lack of awareness about legal issues related to FP. • Patient culture • Patient religion Women with cancer and that possess an internet connected smart phone. (N = 100) • 100% had not received prior instruction about cryopreservation. • 97% had poor knowledge before the intervention. • 95% had satisfactory knowledge after the intervention. • 70% had a negative attitude before the intervention. • 85% had positive attitudes after the intervention. • Poor knowledge and negative attitudes of patients about cryopreservation • Lack of patient teaching about FP. • 58.8% acknowledged the importance of FP. • 56.1% of the patients opted to receive official fertility counseling. • 73.5% were willing to undergo FP, with 40 patients being primarily driven by a desire for future children and 10 patients driven by external influence. • 45.4% of the patients expressed a wish for FP. • Younger nulliparous females, females with higher education, had a greater desire for FP counselling. • In oncologists’ discussions, such as the ability to become pregnant, menstrual periods, potential menopause, and the impact of cancer treatment on fertility, patients reported higher satisfaction levels. • Underappreciation (either did not prioritize their fertility or already had children and were satisfied) • Cost of FP • Fear of treatment delay • Misconceptions (not trusting the process or harboring disproportionate concerns) • Lower educational status • Older, married with children. • Concern about the complications related to the procedure and the treatment. • Lack of information • One patient had undergone FP. • Lack of adequate access in various parts of the country • Prohibitive costs • Lack of insurance coverage • Rushing to start cancer treatment • Priority is to save life from cancer. • Lack of information to patients • Lack of adequate access • Cost • Fear of delaying cancer treatment • Inadequate information to patients FP, fertility preservation; OF, oncofertility Table 2Appraisal of quasi-experimental studiesAuthors1. Is it clear in the study what is the “cause” and what is the “effect”? (No confusion about causality)2. Were the participants included in comparisons similar?3. Were participants in comparisons receiving similar treatments except for the intervention/exposure?4. Was there a control group?5. Were there multiple measurements of the outcome pre- and post-intervention?6. Was follow-up complete? If not, were differences between groups adequately analyzed?7. Were outcomes measured identically across comparison groups?8. Were outcomes measured reliably?9. Was appropriate statistical analysis used?Total Quality score 9(%) Rashed et al., 2018YNANAXYXNAYY4* (66.6) El-Said Mansour & Hassan, 2021.YNANAXYYNAYY5* (83.3) Ibrahim et al., 2023.YNANAXYXNAYY4* (66.6) Saber Nady Mohammed et al., 2024YYYYYYYYY9(100) Gabr et al., 2025YNANAXYXNAYY4* (66.6)NA- Not Applicable; * NA were not included in the denominator; Y – Yes; X – No Table 2Appraisal of quasi-experimental studiesAuthors1. Is it clear in the study what is the “cause” and what is the “effect”? (No confusion about causality)2. Were the participants included in comparisons similar?3. Were participants in comparisons receiving similar treatments except for the intervention/exposure?4. Was there a control group?5. Were there multiple measurements of the outcome pre- and post-intervention?6. Was follow-up complete? If not, were differences between groups adequately analyzed?7. Were outcomes measured identically across comparison groups?8. Were outcomes measured reliably?9. Was appropriate statistical analysis used?Total Quality score 9(%) Rashed et al., 2018YNANAXYXNAYY4* (66.6) El-Said Mansour & Hassan, 2021.YNANAXYYNAYY5* (83.3) Ibrahim et al., 2023.YNANAXYXNAYY4* (66.6) Saber Nady Mohammed et al., 2024YYYYYYYYY9(100) Gabr et al., 2025YNANAXYXNAYY4* (66.6)NA- Not Applicable; * NA were not included in the denominator; Y – Yes; X – No Appraisal of quasi-experimental studies NA- Not Applicable; * NA were not included in the denominator; Y – Yes; X – No Table 3JBI critical appraisal checklist for retrospective studiesAuthors1. Were the groups similar at baseline?2. Was exposure measured validly and reliably?3. Were outcomes defined and assessed objectively?4. Were key confounders (e.g., age, comorbidities) identified?5. Were strategies to address confounders stated (e.g., stratification, regression)?6. Was follow-up ≥ 80% of participants?7. Was the follow-up period sufficient for outcomes to occur?8. Were strategies to address incomplete follow-up described?9. Were outcomes measured uniformly across groups?10. Were analyses aligned with study design (e.g., survival analysis for time-to-event data)?11. Were ethical standards maintained (e.g., IRB approval)?Total Quality score out of 11(%) Rashidi et al., 2018Y*Y*Y*Y*XY*XXYYY5.5 (50) Assi et al., 2020Y*YYYYXXXYYY7.5 (68)* Partially met Table 3JBI critical appraisal checklist for retrospective studiesAuthors1. Were the groups similar at baseline?2. Was exposure measured validly and reliably?3. Were outcomes defined and assessed objectively?4. Were key confounders (e.g., age, comorbidities) identified?5. Were strategies to address confounders stated (e.g., stratification, regression)?6. Was follow-up ≥ 80% of participants?7. Was the follow-up period sufficient for outcomes to occur?8. Were strategies to address incomplete follow-up described?9. Were outcomes measured uniformly across groups?10. Were analyses aligned with study design (e.g., survival analysis for time-to-event data)?11. Were ethical standards maintained (e.g., IRB approval)?Total Quality score out of 11(%) Rashidi et al., 2018Y*Y*Y*Y*XY*XXYYY5.5 (50) Assi et al., 2020Y*YYYYXXXYYY7.5 (68)* Partially met JBI critical appraisal checklist for retrospective studies * Partially met Table 4JBI critical appraisal checklist for qualitative studiesAuthorsIs there congruity between the stated philosophical perspective and the research methodology?Is there congruity between the research methodology and the research question or objectives?Is there congruity between the research methodology and the methods used to collect data?Is there congruity between the research methodology and the representation and analysis of data?Is there congruity between the research methodology and the representation and analysis of data?Is there a statement locating the researcher culturally or theoretically?Is the influence of the researcher on the research, and vice- versa, addressed?Are participants, and their voices, adequately represented?Is the research ethical according to current criteria or, for recent studies, and is there evidence of ethical approval by an appropriate body?Do the conclusions drawn in the research report flow from the analysis, or interpretation, of the data?Total Quality score out of 10(%) Lamyian et al., 2025YYYYYYY*)Y*XX7 (70%)* Partially met Table 4JBI critical appraisal checklist for qualitative studiesAuthorsIs there congruity between the stated philosophical perspective and the research methodology?Is there congruity between the research methodology and the research question or objectives?Is there congruity between the research methodology and the methods used to collect data?Is there congruity between the research methodology and the representation and analysis of data?Is there congruity between the research methodology and the representation and analysis of data?Is there a statement locating the researcher culturally or theoretically?Is the influence of the researcher on the research, and vice- versa, addressed?Are participants, and their voices, adequately represented?Is the research ethical according to current criteria or, for recent studies, and is there evidence of ethical approval by an appropriate body?Do the conclusions drawn in the research report flow from the analysis, or interpretation, of the data?Total Quality score out of 10(%) Lamyian et al., 2025YYYYYYY*)Y*XX7 (70%)* Partially met JBI critical appraisal checklist for qualitative studies * Partially met Data analysis and synthesis The review did not perform a meta-analysis of evidence due to the lack of enough studies using similar designs, and variations in measurements used. For methodological rigor, we used the Synthesis Without Meta-analysis (SWiM) guidelines along with the PRISMA reporting standards to generate a transparent narrative synthesis of the review process [39]. The findings were synthesized using thematic analysis recommended by the Thomas and Harden’s 3-step thematic approach [40] and this includes: Line by line review of study findings by two coders to screen for reoccurring barriers (e.g., religious prohibitions, no specialist referral); Narrative thematic grouping of barriers (e.g., healthcare system, patient, provider, and sociocultural); and analytic theme generation to represent overarching trends. This approach helped us to articulate the major barriers in the MENA regions. Stakeholders including nurses, physicians, and researchers focusing on oncology and FP in Oman, Egypt, Qatar, Morocco, Lebanon, and Iran were consulted. The authors had contacts and prior clinical experience in these countries, and such consultations helped strengthen the external validity of the identified themes and subthemes. Table 5 provides a summary of the themes generated after analyzing the raw data from the twenty-two studies included in the review. Results Study characteristics This review identified 22 eligible articles (Table 1), and these included quantitative cross-sectional (14), quasi-experimental (4), retrospective (2), and qualitative (1) studies. The quality appraisal results showed that cross-sectional studies performed best (28.6% excellence rate), and retrospective cohorts were lower (scoring ≤ 68%) because of poor follow-up. The quasi-experimental studies showed mixed quality – one high-quality-controlled study was balanced by three weak studies without control groups. The only qualitative study in the review had fair capacity to predict actual agreement (70%), despite gaps in reflexivity. Overall, 62% of the quantitative studies did not account for confounders, 71% used suboptimal statistics, and 83% did not have full longitudinal data. One study was multi-country and recruited participants from most MENA countries. Most articles were reporting about studies conducted in Iran (7 studies), Saudi Arabia (4 studies), Egypt (4 studies), and Lebanon (3 studies). The other studies were from Jordan (2 studies) and Oman (1study). The results indicate that FP-related issues remain insufficiently examined across numerous contexts within the MENA region. Main findings The analysis and synthesis led to four (4) key themes that represent barriers to FP, and these are: (1) patient-related barriers; (2) provider-related barriers; (3) healthcare system-related barriers; (4) social and cultural barriers; and agraphical representation of these is provided in Fig. 3. Fig. 3Main themes of barriers to fertility preservation in the MENA region Main themes of barriers to fertility preservation in the MENA region Patient related barriers to FP The patient-related barriers to FP included the factors reported by the cancer patients themselves or the providers as patient’s circumstances, beliefs, and behaviors that affect utilization of FP. The factors that were reported by most of the studies (see Table 5) were patients’ lack of knowledge about FP [17, 18, 21, 23, 26, 30, 34, 36, 37], fear of delaying cancer treatment [18, 21, 23, 24, 26, 28, 37, 38], negative attitudes towards FP [17, 27, 30, 36], and fear of FP complications [18, 21, 37]. The other barriers were highlighted by one study, and these were misconceptions about FP, the patients’ social economic status [37], and fear of breach of confidentiality [21]. The findings show gaps in public and patient education about FP, and a need for interventions to improve knowledge and attitudes and reduce fears. Provider related barriers The provider-related barriers were any factors associated with healthcare professionals that hinder cancer patients’ ability to access or benefit from FP. These barriers encompass a wide range of issues, including a lack of knowledge or skills, communication difficulties, cultural insensitivity, and time constraints. All the provider-related barriers were reported in multiple studies, except the providers’ negative beliefs and fears about children born to patients with cancer [33]. The barriers that were reported by most of the studies were: inadequate knowledge and confidence in information about FP [20, 25, 27, 29, 32, 33], poor patient teaching and education by providers [18–21, 23, 25, 28, 36], provider biases [21, 23, 25, 28, 32], poor communication and information sharing with cancer patients [20, 31, 32, 34, 38], and inadequate psychological support [26, 29, 31, 34, 38]. The other aspects included fear of delaying cancer treatment [29, 31, 33, 38], lack of training and training curriculum emphasis on FP [29, 31, 35], failure to refer patients [25, 33], and lack of awareness of legal aspects of FP [29, 32, 35]. Healthcare system related barrier Healthcare system-related barriers are obstacles within the healthcare system that prevent cancer patients from accessing FP. Many of the studies reported cost of FP services [18, 21, 24, 26, 28, 29, 32, 35–38] and lack of access to FP services [26, 29, 34, 38] as a major barrier. The other healthcare system related barriers include lack of counselling and psychological support services at the FP centers [26, 29, 32, 35], lack of guidelines and lack of utilization of evidence-based guidelines for FP [26, 29, 35], lack of FP consent processes before starting cancer therapies, and legal issues [29]. These barriers are multifaceted and addressing them is crucial for improving access and utilization of FP by cancer patients. The findings also indicate a need for system wide interventions aimed at increasing access to FP, utilization of FP evidence-based guidelines, and strategies to reduce the cost of FP services. Socio-cultural barriers Social-cultural barriers were the hindrances arising from differences in social norms, cultural values, and religious beliefs about FP. Only six studies explicitly reported about social-cultural related barriers. The reported barriers were religious beliefs (Islam) that restrict involvement in FP [19, 29, 35], fear of disrupting virginity in single young women [19], lack of family support [28], and parental control of decisions for young cancer patients [26]. The social-cultural factors identified above show the importance of culture and religion in the MENA region. The small amount of research on socio-cultural topics reflects a reluctance to address cultural and religious matters, or concerns about being misinterpreted, and potential negative reactions from the community. Thus, intervention to enhance uptake of FP must be culturally appropriate, accommodate religious beliefs, and overall Arab culture. Table 5Summary of the thematic analysis of barriers to fertility preservationBarrierStudy ReportingSpecific barrierPatient-related barriers [17, 18, 21, 23, 26, 30, 34, 36, 37]Lack of adequate knowledge about FP [18, 21, 23, 24, 26, 28, 37, 38]Fear of delaying cancer treatment [17, 27, 30, 36]Negative attitude towards FP [18, 21, 37]Fear of complications of FP [19]Lack of knowledge about the complications of cancer treatment related to fertility [37]Misconceptions about FP [21]Fear of breach of confidentiality [37]Social-economic statusProvider-related barriers [20, 25, 27, 29, 32, 33]HPs have inadequate knowledge and confidence in information about FP [18–21, 23, 25, 28, 36]HPs do not provide patient teaching and education [21, 23, 25, 28, 32]HPs have biases related to gender, age, and social status [20, 31, 32, 34, 38]HPs have poor communication and information provision [26, 29, 31, 34, 38]HPs do not provide psychological support [29, 31, 33, 38]HPs fear of delaying cancer treatment [29, 31, 35]HPs lack training, and their curriculum has no emphasis on FP [29, 32, 35]HPs are unaware of legal issues related to FP [25, 33]HPs fail to refer patients to a fertility specialist [33]HPs have negative beliefs and fears about children born to patients with cancerHealthcare system-related barriers [18, 21, 24, 26, 28, 29, 32], 35– [38]Cost of FP services [26, 29, 34, 38]Lack of access to FP services [26, 29, 32, 35]Lack of counseling and psychological support services at FP centers [26, 29, 35]Lack of guidelines and utilization of evidence-based guidelines for FP [29]Lack of the FP consent process before starting cancer therapies [29]Legal issues related to FPSocial-Cultural barriers [19, 29, 35]Religious beliefs (Islam) restrict involvement in FP [28, 29, 35]Cultural limitations [28]Lack of family support [26]Parent preference of cancer treatment and not FP [19]Fear of disrupting virginity in single young womenHPs, healthcare providers; FP, fertility preservation Table 5Summary of the thematic analysis of barriers to fertility preservationBarrierStudy ReportingSpecific barrierPatient-related barriers [17, 18, 21, 23, 26, 30, 34, 36, 37]Lack of adequate knowledge about FP [18, 21, 23, 24, 26, 28, 37, 38]Fear of delaying cancer treatment [17, 27, 30, 36]Negative attitude towards FP [18, 21, 37]Fear of complications of FP [19]Lack of knowledge about the complications of cancer treatment related to fertility [37]Misconceptions about FP [21]Fear of breach of confidentiality [37]Social-economic statusProvider-related barriers [20, 25, 27, 29, 32, 33]HPs have inadequate knowledge and confidence in information about FP [18–21, 23, 25, 28, 36]HPs do not provide patient teaching and education [21, 23, 25, 28, 32]HPs have biases related to gender, age, and social status [20, 31, 32, 34, 38]HPs have poor communication and information provision [26, 29, 31, 34, 38]HPs do not provide psychological support [29, 31, 33, 38]HPs fear of delaying cancer treatment [29, 31, 35]HPs lack training, and their curriculum has no emphasis on FP [29, 32, 35]HPs are unaware of legal issues related to FP [25, 33]HPs fail to refer patients to a fertility specialist [33]HPs have negative beliefs and fears about children born to patients with cancerHealthcare system-related barriers [18, 21, 24, 26, 28, 29, 32], 35– [38]Cost of FP services [26, 29, 34, 38]Lack of access to FP services [26, 29, 32, 35]Lack of counseling and psychological support services at FP centers [26, 29, 35]Lack of guidelines and utilization of evidence-based guidelines for FP [29]Lack of the FP consent process before starting cancer therapies [29]Legal issues related to FPSocial-Cultural barriers [19, 29, 35]Religious beliefs (Islam) restrict involvement in FP [28, 29, 35]Cultural limitations [28]Lack of family support [26]Parent preference of cancer treatment and not FP [19]Fear of disrupting virginity in single young womenHPs, healthcare providers; FP, fertility preservation Summary of the thematic analysis of barriers to fertility preservation HPs, healthcare providers; FP, fertility preservation Discussion This scoping review analyzed twenty-two studies and identified a diverse range of interconnected barriers that potentially impede access and uptake of FP by cancer patients in the MENA region. The findings were synthesized into four themes of patient-related, provider-related, healthcare system-related, and social-cultural related barriers to FP. These barriers collectively illustrate the complex and multifaceted challenges that patients, providers, and healthcare systems face in ensuring access to and utilization of FP services. In the MENA contexts, the barriers are potentially further intensified due to the rich culture and emphasis on religious norms, gender roles, and family structures in social life and during reproductive decision-making. The MENA region is more heterogenous than homogenous; thus, it is important to emphasize that in this large diverse region with large variations in micro and macro cultures, economies, healthcare systems, standards of living, legal systems, and access to healthcare services, generalizability of barriers should be interpreted with precautions. The diversity in domains such healthcare insurance, cost of care, culture, level of affluence, economies, and others might affect the magnitude and perception of the different barriers in each country or even in a specific region of a country. Regarding patient-related barriers, several studies highlighted the poor patient understanding of FP methods, associated risks, and benefits. This contrasts with high-income regions such as Europe, where standardized patient education tools (e.g., digital platforms) address knowledge gaps [41]. In the MENA region, it is possible that inadequate health literacy intersects with cultural and religious taboos surrounding reproduction, yielding challenges related to knowledge and attitudes towards FP. The fear of delaying cancer treatment results in skipping FP or preferring cancer treatment without consideration for FP, is one of such barriers and challenges that may stem from a lack of knowledge and counseling about FP. In developed cancer care systems, FP and cancer treatment are well-coordinated by multidisciplinary teams to ensure informed decision-making by patients and their providers, and this helps to reduce patient anxieties about the future [42]. Misconceptions and negative perceptions surrounding FP, were also common, and these may be in part due to cultural presumptions and stigma towards reproductive technology. Comparable findings have been documented in Southeast Asia, but with less pronounced connections to religion [43]. Patients with low socioeconomic status and unmarried individuals seem to face even more severe challenges when accessing FP due to the synergistic impact of the prohibitive costs, religious and cultural restrictions, bias of healthcare providers, lack of counseling and patient education services, and stigma disincentives. Moreover, reports indicate that in certain areas of the MENA region, the family plays a significant role in healthcare and reproductive decision-making, which can affect individuals’ privacy, autonomy, and confidentiality [44]. Limited individual autonomy and privacy during sensitive matters related to fertility and reproduction could be one of the key barriers, which may sway adults of reproductive age away from considering FP, but instead focus on receiving cancer treatment. The provider-related barriers are also a potential major bottleneck to accessing and uptake of FP in the MENA region, and these include inadequate FP training, biases related to age, diagnoses, and social status of the patient, lack of patient education, and ineffective communication. In more liberal and secular settings such as Canada, biases are less prominent, and the laws prioritize the autonomy of patients [45]. The lack of adequate training, not knowing the laws about FP, and biases could fuel nonreferral to fertility specialists, resulting in practices that do not prioritize or enhance access to FP. In countries such as the USA, FP referrals are required by the Affordable Care Act, and failure to refer can lead to penalties [46]. About healthcare system barriers, the cost of FP and city-centric services leaves behind the rural poor a commonality shared with other low-income settings. The issue of cost of healthcare is not unique to FP because even in the general health services it tends to mostly impact on the less affluent, minority communities, and people living in rural settings. The absence of standardized FP protocols and counseling reflects gaps in cancer care services, and this mirrors challenges reported in Sub-Saharan Africa [47]. Thus, in societies of Africa and the MENA region, where religion and culture are a strong part of the reproductive decisions, there is a need to commit efforts and resources to develop culturally appropriate policies, such as Sharia-aligned FP policies [47]. The healthcare systems in the MENA region also need to consider upgrading the cancer care services with counseling and psychological support services that pay attention to the patients’ needs related to FP. Concerning socio-cultural barriers, parental prioritization of cancer treatment and religious hesitancy reflect collectivist decision-making, and these may be absent in individualistic societies. For example, in Japan, family input is common but rarely overrides patient consent [48]. Fear of disrupting virginity uniquely impacts unmarried women, contrasting with Western society and norms, where FP is framed as a reproductive right [49]. Thus, in some settings of the MENA region, the cancer patient may not perceive family support toward FP, because the support and guidance of the family is always towards maintaining the social, cultural, and religious norms that may be conservative towards reproductive issues. Moreover, various social, cultural, and gender factors influence reproductive decisions in the MENA region, and these are shaped by strong pro-natalist, religious, and patriarchal norms that emphasize marriage-based reproduction, often limiting options for unmarried individuals. For instance, pro-natalism views children as gifts from God, leading to interpretations that may see FP as excessive interference or violation of divine will. Fertility decisions are also often influenced by the male heads of the household and women may have to navigate these decisions through negotiation and after permission from men. In some MENA societies the extended family is highly respected and plays a significant role in reproductive choices, and sometimes the family preferences may be against FP and therefore become a barrier. On the other hand, family lineage continuity is also of paramount importance, and this drives the necessity for biological children, and this can facilitate uptake of FP. The desire for family lineage continuity can also enhance pressure, anxiety, distress, and disappointments in patients with cancer that suffer infertility challenges. Overall, the social, culture, and gender factors are steered by religious beliefs, often prioritizing lineage over individual autonomy, particularly for unmarried women. It is important to note that many of the studies included in the review did not provide in-depth exploration of socio-cultural and religious barriers to FP. This limited attention may reflect concerns about being perceived as critical of culture, religious traditions, or challenging sensitive sociocultural norms in some contexts, particularly where Islamic principles strongly shape reproductive decision-making. Moreover, in some countries, there is also a significant presence of other religions or faith traditions such as Christianity and others. Culturally appropriate interventions to overcome barriers For FP to be a feasible and acceptable option for cancer patients and survivors in the MENA region, we posit that interventions and service models need to be aligned with the predominant Islamic religious bioethical principles and local cultural norms, while also being responsive to the diversity of religious beliefs present across the region and individual preferences. This should be complemented by community awareness campaigns, family oriented FP counseling, and decision-making, while accommodating modesty, collectivism, and Islamic alms such as zakat and waqf to enhance access among those with limited financial means. Supporting peers support groups for cancer patients and community health workers as cultural brokers and ensuring legal protection for the rights of minors and unmarried individuals to store gametes will also go a long way to promote equity and fairness. Overall, we propose that all interventions must at the core be culturally sensitive and utilize a multi-sectoral model for FP development. Implications for healthcare practice To address the barriers among cancer patients in the MENA region, the cancer care system must initiate efforts towards public and religious community engagement, healthcare workforce development, and legal and financial support plans to support cancer patients’ access to FP. We recommend system level interventions focusing on integrating culturally sensitive strategies that ensure: early FP discussions in cancer care pathways; FP counseling and psychological support that is aligned with predominant religious principles and bioethics; patient and public education provided by healthcare professional and religious advisors; evidence based clinical guidelines and protocol that considers the local context; health professions training curriculum enhanced with content on FP; patient navigation services focusing on FP; patient peer support groups for FP; patient-focused storytelling to sensitive the public and reduce stigma; clinician cultural competency training programs; policies to subsidize the cost of FP such as zakat funds; expansion of FP services to remote settings; and local research and studies to develop tailored solutions that balance progressive care with socioreligious sensitivities. In summary, to improve access to FP among cancer patients in the MENA region, healthcare systems should consider adopting culturally sensitive and multidisciplinary approaches. The key actions may include integrating early FP discussions into oncology care, following standardized clinical guidelines, enhancing provider and patient education, and fostering collaboration across specialties. Efforts should also focus on advocating for affordable FP services as well as supporting region-specific research to guide evidence-based, culturally appropriate interventions. Strengths This is the first review to map the barriers to FP among patients with cancer in the MENA region. Therefore, the review addressed a relevant and under explored topic in the region and provides a foundational map of barriers that can be used to broaden research in this field, developing strategies to improve public awareness and uptake of FP, and improve the quality of cancer care services in the region. Moreover, the scoping review approach helped us to adopt a flexible, transparent, and iterative approach, allowing for the consideration and inclusion of diverse study designs and grey literature. The review considered findings from both qualitative and quantitative studies, hence providing a more comprehensive picture of the barriers from the perspective of the patients with cancer, family members, and health care providers. The review included studies from countries in the MENA with largest populations and where FP is most common such as Saudi Arabia, Egypt, Lebanon, and Jordan. Limitations This review has several limitations. First, the limited number of studies and the predominance of the studies using descriptive designs limit the depth of our understanding of the barriers. Secondly, the inclusion of only articles in English may have introduced language bias, excluding relevant studies published in other languages used in the region such as Arabic, Persian, French, and others. However, the predominant majority of scientific studies related to nursing, medicine, and healthcare from the MENA region are published in English. Thirdly, there was a geographic imbalance regarding countries where studies were conducted, with most studies originating from Iran, Saudi Arabia, and Egypt. These are the countries with the largest populations in the MENA. This dominance by the most populated MENA countries limits the representation of barriers from less populated and conflict-affected settings. Fourth, although the quality of studies was appraised using the JBI checklists, the scoping methodology inherently includes studies of varying rigor, which may affect the reliability and generalizability of conclusions. Conclusion This scoping review provides preliminary insights into the potential barriers to FP reported in parts of the MENA region. The patient, healthcare provider, healthcare system, and sociocultural factors intersect to hinder equitable access to FP services. Addressing these challenges requires multidisciplinary and culturally appropriate approaches that incorporate enhanced curricula for health professions education, policy development, financial support mechanisms, and religious engagement. We recommend future research that explores interventions to address access and uptake by underrepresented populations, particularly in low-resource or conflict-affected settings. We also recommend more mixed-methods studies and qualitative studies to explore the lived experiences, the dynamics involved in FP decision making, and overall awareness and attitudes towards FP. Ensuring reproductive autonomy for cancer survivors in the region will potentially depend on systemic transformation guided by empathy, evidence, and cultural insight.